Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 6.88 · gapped below the open, then crossed back over prior close. High/low 6.94 at 2:00 pm ET, 6.70 at 10:45 am ET.
Entrada Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“For example, we currently have a license from OSIF, an affiliate of The Ohio State University ("OSU") to certain patent rights and know-how of OSU.”
FILING10-K0001689375-26-000011cik 0001689375
“For example, in November 2025, we entered into a sales agreement (the "Sales Agreement") with TD Securities (USA) LLC (f/k/a Cowen and Company, LLC) acting as our agent and/or principal (the "Sales Agent"), with respect to an "at the market offering" program under which we may offer and sell, from time to time, at our sole discretion, shares of common stock having an aggregate offering price of up to $150.0 million through the Sales Agent.”
FILING10-K0001689375-26-000011cik 0001689375
“Substantially all of our revenue to date has been derived from the Vertex Agreement.”
FILING10-K0001689375-26-000011cik 0001689375
“We have generated a number of EEV-enzyme conjugates, including PTI-501 for MNGIE, a fatal mitochondrial disease, for which we have completed IND-enabling studies and licensed to Pierrepont Therapeutics, Inc. in 2023.”
FILING10-K0001689375-26-000011cik 0001689375
Watchlist prices, news filtered to it, and its next report on your desk.
Entrada Therapeutics, Inc. has 2 disclosed suppliers and 2 disclosed customers. Each one is named in an SEC filing, either Entrada Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
TRDA (Entrada Therapeutics, Inc.) has 2 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: VRTX −1.05%, in healthcare.